Cetera Investment Advisers Biomarin Pharmaceutical Inc Transaction History

Cetera Investment Advisers

$44.2 Billion
Q3 2024

A detailed history of Cetera Investment Advisers transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Cetera Investment Advisers holds 7,454 shares of BMRN stock, worth $472,732. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,454

Previous 11,692 36.25%

Holding current value

$472,732

Previous $962,000 45.63%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$69.02 - $93.84 $292,506 - $397,693	-4,238 Reduced 36.25%	7,454 $523,000
Q2 2024 Aug 22, 2024	SELL	$74.43 - $92.22 $324,291 - $401,802	-4,357 Reduced 27.15%	11,692 $962,000
Q1 2024 May 24, 2024	BUY	$83.81 - $99.0 $1.35 Million - $1.59 Million	16,049 New	16,049 $1.4 Million
Q4 2023 Feb 13, 2024	BUY	$76.22 - $98.51 $14,786 - $19,110	194 Added 4.02%	5,019 $483,000
Q3 2023 Nov 14, 2023	BUY	$85.07 - $94.48 $20,246 - $22,486	238 Added 5.19%	4,825 $426,000
Q2 2023 Aug 09, 2023	BUY	$86.68 - $100.3 $91,620 - $106,017	1,057 Added 29.94%	4,587 $397,000
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $5,176 - $6,918	59 Added 1.7%	3,530 $343,000
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $30,025 - $40,301	371 Added 11.97%	3,471 $359,000
Q3 2022 Nov 10, 2022	SELL	$82.16 - $96.94 $15,528 - $18,321	-189 Reduced 5.75%	3,100 $263,000
Q2 2022 Aug 11, 2022	SELL	$71.48 - $86.85 $190,851 - $231,889	-2,670 Reduced 44.81%	3,289 $273,000
Q1 2022 May 13, 2022	SELL	$74.28 - $92.69 $37,957 - $47,364	-511 Reduced 7.9%	5,959 $459,000
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $26,536 - $33,843	370 Added 6.07%	6,470 $572,000
Q3 2021 Nov 16, 2021	BUY	$74.77 - $85.47 $36,113 - $41,282	483 Added 8.6%	6,100 $471,000
Q2 2021 Aug 13, 2021	BUY	$75.51 - $84.79 $424,139 - $476,265	5,617 New	5,617 $469,000
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $201,397 - $244,409	-2,695 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$72.61 - $90.2 $195,683 - $243,089	2,695 New	2,695 $236,000

Others Institutions Holding BMRN

# of Institutions

635

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Account

Cetera Investment Advisers Biomarin Pharmaceutical Inc Transaction History